Related Experiment Videos
Melatonin - a chronobiotic and soporific hormone
1Sleep Laboratory, Faculty of Medicine, Gutwirth Building, Technion City, Haifa 32000, Israel.
Archives of Gerontology and Geriatrics
|March 1, 1997
Summary
Melatonin, a hormone regulating sleep-wake cycles, is often deficient in elderly insomniacs. Melatonin replacement therapy may improve sleep initiation and maintenance in older adults with this condition.
Area of Science:
- Neuroscience
- Chronobiology
- Endocrinology
Background:
- Melatonin, a pineal gland hormone, synchronizes the sleep/wake cycle.
- Melatonin production is regulated by the suprachiasmatic nucleus (SCN) in the hypothalamus, which responds to light.
- Sleep disturbances, including insomnia and daytime drowsiness, are common in the elderly.
Purpose of the Study:
- To review evidence linking impaired melatonin secretion to sleep disorders in the elderly.
- To investigate the efficacy of melatonin treatment for melatonin-deficient insomnia in older adults.
Main Methods:
- Review of existing evidence on melatonin secretion and aging-related sleep changes.
- Investigation of melatonin treatment effects in elderly individuals with diagnosed insomnia and low melatonin levels.
Main Results:
- Elderly insomniacs exhibit significantly lower circulating melatonin levels compared to controls.
- Delayed onset and peak times of melatonin secretion were observed in elderly insomniacs.
- Melatonin replacement therapy showed potential benefits for sleep initiation and maintenance in the studied population.
Conclusions:
- Impaired melatonin secretion is associated with sleep disorders in the elderly population.
- Melatonin replacement therapy may be a viable treatment option for insomnia in older adults with melatonin deficiency.